American Century Companies Inc Cytom X Therapeutics, Inc. Transaction History

American Century Companies Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.61 - $8.6 $157,547 - $375,321	-43,642 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$5.17 - $8.91 $408,068 - $703,266	-78,930 Reduced 64.39%	43,642 $363,000
Q3 2019 Nov 13, 2019	BUY	$7.38 - $12.25 $904,581 - $1.5 Million	122,572 New	122,572 $905,000
Q4 2018 Feb 13, 2019	SELL	$12.69 - $18.61 $1.98 Million - $2.91 Million	-156,248 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$18.04 - $26.41 $16,795 - $24,587	931 Added 0.6%	156,248 $2.89 Million
Q2 2018 Aug 08, 2018	SELL	$21.38 - $29.68 $1.06 Million - $1.48 Million	-49,743 Reduced 24.26%	155,317 $3.55 Million
Q1 2018 May 03, 2018	SELL	$21.76 - $34.22 $2.24 Million - $3.52 Million	-102,758 Reduced 33.38%	205,060 $5.83 Million
Q4 2017 Feb 02, 2018	BUY	$19.0 - $23.09 $2.62 Million - $3.19 Million	138,019 Added 81.28%	307,818 $6.5 Million
Q3 2017 Nov 01, 2017	BUY	$13.53 - $18.17 $2.3 Million - $3.09 Million	169,799	169,799 $3.09 Million

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.